August 5, 2025
Read
August 5, 2025

Breastfeeding, BRCA, and Beyond: Why High-Risk Women Still Need Earlier Imaging

Reviewed By:
Breastfeeding, BRCA, and Beyond: Why High-Risk Women Still Need Earlier Imaging

Contents

Table of contents placeholder

Breastfeeding can reduce a BRCA1 carrier's lifetime risk of breast cancer by about 32%. However, the starting line is so high, up to 60%, that even a diligent nursing history cannot reduce the risk to the average. Current guidelines call for annual MRI from age 25-<40, with mammograms added at 40, because missing a tumour in these women can cost decades of life.

Key Facts at a Glance

Understanding your risk of cancer can be complicated. It becomes even more complex when multiple factors are impacting breast cancer risk at the same time. Key statistics to be aware of include:

  • Baseline risk: BRCA1 ≈ 60% and BRCA2 ≈ 45% lifetime risk1.
  • Risk reduction with breastfeeding: 32% for BRCA1; no proven drop for BRCA22.
  • Baseline risk for all women: 1 in 7, about 14%3.
  • MRI advantage: MRI plus mammogram detects 9-100% of cancers in high-risk young women vs ≈ 25-59% for mammograms alone4.
  • Start line: Annual MRI starting at age 25 for BRCA1/2 carriers5.

Screening recommendations can vary depending on the presence of other risk factors such as mutations other than BRCA1 and previous radiotherapy on breast tissue5.

Why Breastfeeding Helps but Doesn’t Erase High Risk

It may come as a surprise to learn that breastfeeding can reduce the risk of breast cancer for BRCA1 carriers. There are several potential mechanisms behind this connection.

HTML Table
Mechanism What Nursing Does Role of BRCA Mutation
Fewer stem cells² Encourages the development of stem cells into cells that promote milk production Prevents stem cells from differentiating into milk-producing cells, creating more opportunities for cancer development
Slower tissue remodelling⁶ Breast tissue remodelling after long periods of nursing is slower and less likely to generate inflammation and higher cell proliferation Not reported
Hormonal reset⁷,⁸ Pregnancy and lactation reduce ovulation and the circulation of specific hormones such as oestrogen Unknown, but BRCA tumours are often triple-negative, and oestrogen exposure is only part of the equation
Excretion of hormones and carcinogens⁹ Oestrogen and carcinogens may be excreted in breast milk, reducing the chances of cancer development Not reported

Imaging Timetable for High-risk Postpartum Women

Breast cancer screening programmes are customised based on individual risk factors. In the UK, MRI is not recommended during pregnancy or lactation, as changes to breast tissue during these times can impact image quality and reduce the benefits of MRI. Screening can resume three months after giving birth and after the cessation of breastfeeding for women who opt out of screening due to pregnancy or lactation5,10.

HTML Table
Age Recommended Test
25 - <40 Annual breast MRI
40 - <51 Annual breast MRI + Mammography
51 - <71 Annual mammography with or without MRI
During pregnancy and lactation MRI is not recommended. Mammography is preferred, though its effectiveness may be reduced.

Beyond Imaging: Complementary Risk Reducers

There is a wide array of factors that can contribute to higher breast cancer risk. Fortunately, there are several behavioural changes and treatment options that can help to reduce it. These include:

  1. Weight vigilance - Maintaining a healthy weight is important, as a body mass index (BMI) of 30 or above is associated with a 70% higher risk of post-menopausal breast cancer11.
  2. Alcohol cap - Limiting alcohol intake is advised, since each additional daily drink (10 grams of alcohol) increases the relative risk of breast cancer by approximately 7%12. Limiting alcohol consumption to less than 14 units a week may help to lower the risk13.
  3. Chemoprevention - Medications such as tamoxifen and raloxifene may reduce breast cancer risk for individuals with BRCA1/2 mutations14.
  4. Prophylactic surgery - Risk-reducing bilateral mastectomy can lower the likelihood of developing breast cancer by over 90% for people at high risk, such as those with BRCA mutations15. However, the decision and timing of surgery are highly personal and depend on individual circumstances.

Barriers to Screening Services for Breast Cancer

Despite improvements in our understanding of breast cancer risk, significant barriers remain that prevent women from benefiting from MRI screening. It is estimated that about 73 preventable breast cancer deaths occur in the UK each year due to unequal access to screening infrastructure16.

Besides accessibility issues, women may avoid attending breast screening appointments due to not thinking they are at risk, fear of pain during the screening, fear of a cancer diagnosis, lack of time, and poor accessibility, among others17.

Mobile screening units offer a potential solution by bringing screening services closer to women with limited mobility or living in more remote areas. Improved engagement of healthcare bodies with faith-based groups or social networks can help to improve awareness of breast screening programmes among historically underserved communities17.

Talk to Your Healthcare Provider

Every individual has a unique set of risk factors relating to breast cancer. An important first step is understanding your risk, which can involve attending a genetic counselling service. If close relatives of yours have had ovarian or breast cancer, you may be entitled to an NHS genetic test, which can identify high-risk mutations such as those in BRCA genes18.

If you are in a high-risk category and are pregnant or have recently given birth and are breastfeeding, it’s important to discuss your screening options with your doctor. They will be able to advise you on the pros and cons of continuing screening as usual or waiting until after pregnancy and breastfeeding19.

Summary: Breastfeeding, BRCA, and Beyond

Breastfeeding can lower the risk of breast cancer in individuals with BRCA1 mutations, but on its own, it does not eliminate the elevated risk. Early, MRI-based surveillance remains a crucial tool for early cancer detection, as does overcoming barriers to accessing screening infrastructure. Getting informed about your risk and discussing your screening options with your healthcare provider can help you to make informed decisions about your health, through pregnancy, breastfeeding, and beyond.

If you want to be proactive about your breast health, consider booking an Ezra MRI scan. Our service helps to detect abnormalities early, giving you the best chance of early treatment and improved outcomes.

Understand your risk for cancer with our 5 minute quiz.

Our scan is designed to detect potential cancer early.

References

1. Godet I, Gilkes DM. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. 2017;4(1). doi:10.15761/ICST.1000228 

2. Kotsopoulos J, Lubinski J, Salmena L, et al. Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2012;14(2):R42. doi:10.1186/bcr3138 

3. Breast cancer risk. Cancer Research UK. May 14, 2015. Accessed August 5, 2025. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/risk-factors 

4. Lord SJ, Lei W, Craft P, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007;43(13):1905-1917. doi:10.1016/j.ejca.2007.06.007 

5. Eligibility criteria and screening protocols for women at very high risk of breast cancer. GOV.UK. Accessed August 5, 2025. https://www.gov.uk/government/publications/breast-screening-higher-risk-women-surveillance-protocols/tests-and-frequency-of-testing-for-women-at-very-high-risk--2 

6. Ye DM, Bai X, Xu S, et al. Association between breastfeeding, mammographic density, and breast cancer risk: a review. Int Breastfeed J. 2024;19(1):65. doi:10.1186/s13006-024-00672-7 

7. Gustbée E, Anesten C, Markkula A, et al. Excessive milk production during breast-feeding prior to breast cancer diagnosis is associated with increased risk for early events. SpringerPlus. 2013;2(1):298. doi:10.1186/2193-1801-2-298 

8. Bothou A, Zervoudis S, Iliadou M, et al. Breastfeeding and Breast Cancer Risk: Our Experience and Mini-review of the Literature. Mater Sociomed. 2022;34(1):28. doi:10.5455/msm.2022.33.28-32 

9. Work ME, John EM, Andrulis IL, et al. Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. Br J Cancer. 2014;110(5):1367-1377. doi:10.1038/bjc.2013.807 

10. Breast screening: guidance for organising a Very High Risk (VHR) screening programme. GOV.UK. Accessed August 5, 2025. https://www.gov.uk/government/publications/breast-screening-screening-of-higher-risk-women/breast-screening-guidance-for-organising-a-very-high-risk-vhr-screening-programme 

11. Cecchini RS, Costantino JP, Cauley JA, et al. Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila). 2012;5(4):583-592. doi:10.1158/1940-6207.CAPR-11-0482 

12. McDonald JA, Goyal A, Terry MB. Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence. Curr Breast Cancer Rep. 2013;5(3). doi:10.1007/s12609-013-0114-z 

13. Causes of breast cancer in women. nhs.uk. March 15, 2024. Accessed August 5, 2025. https://www.nhs.uk/conditions/breast-cancer-in-women/causes-of-breast-cancer-in-women/ 

14. Alwashmi ASS, Khan NU, Chen T. Risk-benefits assessment of tamoxifen or raloxifene as chemoprevention for risk reduction of breast cancer among BRCA1 and BRCA2 carriers: a meta-analysis. Sci Rep. 2025;15(1):6796. doi:10.1038/s41598-025-89915-z 

15. Mastectomy. NHS inform. Accessed August 5, 2025. https://www.nhsinform.scot/tests-and-treatments/surgical-procedures/mastectomy/ 

16. Evans DG, Edwards M, Duffy SW, Cancer Genetics Group clinical leads, Tischkowitz M. Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication. Br J Cancer. 2020;122(3):329-332. doi:10.1038/s41416-019-0631-2 

17. Breast screening: reducing inequalities. GOV.UK. Accessed August 5, 2025. https://www.gov.uk/government/publications/breast-screening-identifying-and-reducing-inequalities/breast-screening-reducing-inequalities 

18. Risk factors for breast cancer. Accessed August 5, 2025. https://www.cancerresearchuk.org/about-cancer/breast-cancer/risks-causes/risk-factors 

19. The Surveillance of women at very high risk of developing breast cancer. GOV.UK. Accessed August 5, 2025. https://www.gov.uk/government/publications/breast-screening-higher-risk-women-surveillance-protocols/protocols-for-surveillance-of-women-at-higher-risk-of-developing-breast-cancer